{"protocolSection":{"identificationModule":{"nctId":"NCT01655160","orgStudyIdInfo":{"id":"100-4548B"},"organization":{"fullName":"Chang Gung Memorial Hospital","class":"OTHER"},"briefTitle":"Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke","officialTitle":"Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke: Outcomes in Brain and Movement Reorganization, Sensorimotor and Daily Functions, and Measures of Physiological Markers."},"statusModule":{"statusVerifiedDate":"2015-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-08"},"primaryCompletionDateStruct":{"date":"2015-03","type":"ACTUAL"},"completionDateStruct":{"date":"2015-03","type":"ACTUAL"},"studyFirstSubmitDate":"2012-07-30","studyFirstSubmitQcDate":"2012-07-31","studyFirstPostDateStruct":{"date":"2012-08-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-06-04","lastUpdatePostDateStruct":{"date":"2015-06-08","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Chang Gung Memorial Hospital","class":"OTHER"},"collaborators":[{"name":"National Science Council, Taiwan","class":"OTHER_GOV"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of this study will evaluate the long-term benefits, optimal dose and mechanisms of mirror therapy and its effects on physiological markers.","detailedDescription":"This trial is to examine whether (1) the immediate effects of treatment intensity in MT would occur on sensorimotor impairments and functional performance in patients with subacute stroke; (2) the long-term benefits of treatment intensity in MT on functionality can persist for six months after treatment finished; and (3) the MT could result in cortical/movement reorganization as well as the changes in physiological markers."},"conditionsModule":{"conditions":["Cerebrovascular Accident"],"keywords":["Stroke rehabilitation","Mirror therapy","Functional performance","Kinematic analysis","Functional magnetic resonance image","Motor recovery"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":2,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"mirror therapy treatment","type":"EXPERIMENTAL","description":"Three groups will be involved in this part of the whole project:MT with low-intensity group (MT-LI), MT with moderate-intensity group (MT-MI), MT with high-intensity group (MT-HI)","interventionNames":["Behavioral: MT with low-intensity group (MT-LI)","Behavioral: MT with moderate-intensity group","Behavioral: Mirror therapy with high intensity group"]},{"label":"control intervention group","type":"ACTIVE_COMPARATOR","description":"The part of this project will involve 1 treatment groups:control intervention group (CI)","interventionNames":["Behavioral: Control intervention group"]}],"interventions":[{"type":"BEHAVIORAL","name":"MT with low-intensity group (MT-LI)","description":"The MT-LI group will receive a 30-minute MT per session followed by a 30-minute functional training.","armGroupLabels":["mirror therapy treatment"],"otherNames":["MT-LI"]},{"type":"BEHAVIORAL","name":"MT with moderate-intensity group","description":"The MT-MI group will receive a 60-minute MT per session followed by a 30-minute functional training.","armGroupLabels":["mirror therapy treatment"],"otherNames":["MT-MI"]},{"type":"BEHAVIORAL","name":"Mirror therapy with high intensity group","description":"The MT-HI group will receive a 90-minute MT per session followed by a 30-minute functional training","armGroupLabels":["mirror therapy treatment"],"otherNames":["MT-HI"]},{"type":"BEHAVIORAL","name":"Control intervention group","description":"The CI group will carry out a 30-minute conventional stroke rehabilitation training per session followed by a 30-minute functional training.","armGroupLabels":["control intervention group"],"otherNames":["CI"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Fugl-Meyer Assessment (FMA)","description":"The UE subscale of the FMA (max. score 66) uses a 3-point ordinal scale to assess motor impairment.","timeFrame":"Baseline, change from baseline in FMA at 2 weeks, and change from baseline in FMA at 4 weeks"},{"measure":"Action Research Arm Test (ARAT)","description":"ARAT will be used to assess the motor function of UE. A total of 19 items are to test the movement of grasp, grip, pinch, and gross motor, with a scale of 0-3 for each item (maximal of 57).","timeFrame":"Baseline, change of ARAT at 2 weeks, and change of ARAT at 4 weeks"},{"measure":"Motor Activity Log (MAL)","description":"The MAL is a semi-structured interview of patients to assess the amount of use (AOU) and quality of movement (QOM) of the affected upper extremity in 30 important daily activities using a 6-point ordinal scale. Higher scores indicate better performance.","timeFrame":"Baseline, change of MAL at 2 weeks, and change of MAL at 4 weeks"},{"measure":"ABILHAND Questionnaire","description":"ABILHAND questionnaire is an inventory of 56 manual activities that uses a 3-point ordinal scale to measure subjectively perceived difficulty in performing everyday bimanual activity.","timeFrame":"Baseline, change of ABILHAND Questionnaire at 2 weeks, and change of ABILHAND Questionnaire at 4 weeks"},{"measure":"Adelaide Activities Profile (AAP)","description":"AAP will be applied to indicate the level of participation in household and community activities. This profile includes 21 activities in the four areas: domestic chores, household maintenance, service to others, and social activities.","timeFrame":"Baseline, change of AAP at 2 weeks, and change of AAP at 4 weeks"}],"secondaryOutcomes":[{"measure":"Functional magnetic resonance imaging (fMRI)","description":"uses the blood oxygenation level-dependent (BOLD) response to evaluate the brain reorganization after intervention.","timeFrame":"Baseline and change of fMRI at 4 weeks"},{"measure":"Physiological marker measures","description":"measure inflammatory markers, oxidative stress markers, and erythrocyte deformability.","timeFrame":"Baseline and change from baseline in physiological marker measures at 4 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* first episode of stroke in cortical regions\n* time since stroke less than 3 months\n* initial motor part of UE of FMA score ranging from 24 to 52\n* no serious cognitive impairment\n\nExclusion Criteria:\n\n* aphasia\n* visual impairments\n* major health problems or poor physical conditions\n* currently participation in any other","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Ching-yi Wu, ScD","affiliation":"Chang Gung University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Chang Gung Memorial Hospital","city":"Kwei-shan","state":"Toayuan county","country":"Taiwan"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Cerebrovascular Accident","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}